- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05203198
The PATHway Study: Primary Care Based Depression Prevention in Adolescents (PATHway)
January 6, 2026 updated by: Benjamin Van Voorhees, MD, MPH, University of Illinois at Chicago
Primary Care Based Depression Prevention in Adolescents: Intervention Optimization in Preparation for Implementation Study
Prevention of depressive disorders has become a key priority for the NIMH, but the investigators have no widely available public health strategy to reduce morbidity and mortality.
To address this need, the investigators developed and evaluated the primary care based-technology "behavioral vaccine," Competent Adulthood Transition with Cognitive-Behavioral Humanistic and Interpersonal Therapy (CATCH-IT).
The investigators will engage N=4 health systems representative of the United States health care system, and conduct a factorial design study to optimize the intervention in preparation for an implementation study and eventual dissemination.
Study Overview
Status
Active, not recruiting
Conditions
Detailed Description
With more than 13% of adolescents diagnosed with depressive disorders each year, prevention of depressive disorders has become a key priority for the National Institute of Mental Health (NIMH).
Unfortunately, the investigators have no widely available interventions to reduce morbidity and mortality (e.g.
public health impact).
To address this need, the investigators developed a multi-health system "collaboratory" to develop and evaluate the primary care based technology "behavioral vaccine," Competent Adulthood Transition with Cognitive-Behavioral Humanistic and Interpersonal Therapy (CATCH-IT) (14 adolescent, 5 parent modules).
Using this health-system collaboratory model, the full CATCH-IT program (all modules), demonstrated evidence of efficacy in prevention of depressive episodes in phase-three clinical trials in the United States and China.
However, like many "package" interventions, CATCH-IT became larger and more complex across efficacy trials.
Thus, adolescents were less willing to complete all 14 modules, suggesting adolescent dose "tolerability" issues (e.g., satisfaction, acceptability and resource use, "time as cost").
Similarly, primary care practices have "scalability" challenges (acceptability, feasibility, resource use, cost), resulting in declining REACH (percent of at-risk youth who complete intervention).
To prepare for implementation studies and dissemination, the investigators need to address adolescent tolerability and practice/health system scalability, while preserving efficacy.
Multiphase Optimization Strategy (MOST) uses a systematic analytic approach and a factorial randomized clinical trial design to address efficacy, tolerability, and scalability, simultaneously.
The investigators will use a MOST approach to optimize CATCH-IT for the prevention of depression (indicated prevention, i.e., elevated symptoms of depression) in practices and health systems representative of US geography and population.
The theoretically grounded components of CATCH-IT selected for study and optimization include: behavioral activation, cognitive-behavioral therapy, interpersonal psychotherapy, and parent program.
The investigators will use a 4-factor (2x2x2x2) fully crossed factorial design with N=16 cells (25 per cell, 15% dropout) to evaluate the contribution of each component.
The investigators propose to randomize N=400 adolescents from multiple sites: Advocate-Aurora Health Care (n=200); Lurie Children's Hospital (n=70); NorthShore University HealthSystem (n=70); University of Chicago Comer Hospital (n=25); University of Texas (n=20); University of Illinois College of Medicine Peoria (n=15).
The at-risk youth will be high school students 13 through 18 years old, not currently experiencing a mood disorder, but with subsyndromal symptoms of depression (moderate to high risk).
Using the efficient factorial design, the investigators can assess the contribution to prevention efficacy of each component.
Thus, the MOST study design will enable us to eliminate non-contributing components while preserving efficacy and to optimize CATCH-IT by strengthening tolerability and scalability by reducing "resource use."
By reducing resource use, the investigators anticipate satisfaction and acceptability will also increase, preparing the way for an implementation trial and eventual US Preventive Services Task Force endorsement to support dissemination.
Thus, the primary question is whether one component, or perhaps two, can demonstrate an equivalent effect to combinations of other components in terms of efficacy, whilst also demonstrating superior adolescent/family tolerability scalability over a 12-month follow-up.
Study Type
Interventional
Enrollment (Actual)
400
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Ann & Robert H. Lurie Children's Hospital of Chicago
-
Chicago, Illinois, United States, 60637
- University of Chicago Comer Children's Hospital
-
Chicago, Illinois, United States, 60612
- UI Health
-
Glenview, Illinois, United States, 60026
- NorthShore University Healthsystem
-
Park Ridge, Illinois, United States, 60068
- Advocate Aurora Health
-
-
Texas
-
Dallas, Texas, United States, 75390
- UT Southwestern Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adolescents ages 13 through 18 years, and
- Adolescents must be experiencing an elevated level of depressive symptoms (PHQ-9 = 5-18), and
- Adolescents will be included if they have had past depressive episode/s, but not if they are in a current depressive episode.
Exclusion Criteria:
Outside age range:
- 12 or younger
- 19 or older
- Adolescent is a non-English speaker/reader
On the PHQ-9 screening, depression symptom level is:
- PHQ-9 = 4 or lower
- PHQ-9 =19 or higher
- As assessed by the MINI Kid, a current depressive episode
- As assessed by the MINI Kid, adolescent meets DSM-5 criteria for a psychotic or bipolar disorder.
- Currently using medication therapy for depression, anxiety, or other internalizing disorders.
- Currently engaged in individual treatment for a mood disorder (assessed by BCC during phone screen)
- Currently engaged in a cognitive-behavioral group or therapy (assessed by BCC during phone screen)
- Any past psychiatric hospitalizations
- Any past suicide attempt or incident of self-harm with moderate or greater lethality
- Extreme, current drug/alcohol abuse (determined by clinician follow up following a score of 3 or greater on the CRAFFT)
Current suicidal thoughts
- Eligibility will be determined on a case-by-case basis during the baseline PhQ-9 and MINI Kid assessment process and after a consultation with a licensed mental health clinician has taken place. If adolescent report suicidal ideation on the baseline PhQ-9, and found ineligible, the MINI Kid assessment may not be required.
- Adolescents with current (within the past 6 months), active suicidal feelings will be excluded.
- Adolescents with passive thoughts of death or suicide but report to the mental health clinician that they would never act on these thoughts may be admitted, depending on the severity of the risk.
- Adolescents with past (greater than 6 months ago) ideation who are determined to be low risk will be admitted into the study if there has never been an attempt of moderate or greater lethality.
- Significant reading impairment (a minimum sixth-grade reading level based on parental report) and/or significant intellectual or developmental disabilities
- Not willing to comply with the study protocol
- Did not complete phone assessment with MINI Kid by BCC
- Not affiliated with any of the sites listed in Appendix A.
- Parent/guardian does not speak English or Spanish
- Parent/guardian has a cognitive or intellectual impairment
- Participant Declined/Changed Mind/Uninterested in participating
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: 1. No adolescent modules + no parent modules
No adolescent nor parent modules will be offered to the participant.
|
|
|
Experimental: 2. Adolescent behavioral activation modules only
Adolescent behavioral activation modules only
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 3. Adolescent cognitive-behavioral therapy modules only
Adolescent cognitive-behavioral therapy modules only
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 4. Adolescent interpersonal therapy modules only
Adolescent interpersonal therapy modules only
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 5. Adolescent behavioral activation modules + cognitive-behavioral therapy modules
Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 6. Adolescent behavioral activation modules + interpersonal therapy modules
Adolescent behavioral activation modules Adolescent interpersonal therapy modules
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 7. Adolescent cognitive-behavioral therapy modules + interpersonal therapy modules
Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 8. Full Adolescent program only
Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 9. Parent program modules only
Parent program modules
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 10. Adolescent behavioral activation modules + parent program modules
Adolescent behavioral activation modules Parent program modules
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 11. Adolescent cognitive-behavioral therapy modules + parent program modules
Adolescent cognitive-behavioral therapy modules Parent program modules
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 12. Adolescent interpersonal therapy modules + parent program modules
Adolescent interpersonal therapy modules Parent Program
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 13. Adolescent behavioral activation + cognitive-behavioral therapy + parent program modules
Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Parent program modules
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 14. Adolescent behavioral activation + interpersonal therapy + parent program modules
Adolescent behavioral activation modules Adolescent interpersonal therapy modules Parent program modules
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Experimental: 15. Adolescent cognitive-behavioral therapy + interpersonal therapy + parent program modules
Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules Parent program modules
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
|
Active Comparator: 16. All adolescent + parent program modules
Adolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules Parent program modules
|
Self-directed, technology-based, depression prevention program for adolescents and parents.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time
Time Frame: Baseline through 12 months
|
Time will be measured to nearest minute for all intervention related activities including initial screening, engagement phone calls, use of CATCH-IT.
Time will be measured from adolescent, family, practice, community center, healthcare organization, health system perspective.
For time that cannot be directly measured by study staff, the investigators will sample direct observation or questionnaires to capture time required for health system related activities such as screening and engagement.
|
Baseline through 12 months
|
|
Cultural acceptability adolescent and family
Time Frame: Baseline through 12 months
|
Cultural acceptability for each stakeholder using appropriate, validated instruments.
Adolescent and family: Usefulness, Satisfaction, and Ease Questionnaire (USE, 30 items, self-report, 7-point Likert scale, 30-210 score range, higher score indicates more acceptable).
An example statement is: "I would recommend this to a friend."
|
Baseline through 12 months
|
|
Cost
Time Frame: Baseline through 12 months
|
Costs will be measured for all stakeholders.
For practice, community center, healthcare organizations, health systems, cost will be measured to nearest dollar by converting time measures into employment related costs based on mean wages and benefits for staff at that occupational level.
Adolescent and family costs will be measured by converting time into mean hourly wages and benefits for adolescent and family members involved in the project (based on mean wage for age and occupation).
|
Baseline through 12 months
|
|
Depressive Symptoms
Time Frame: Baseline through 12 months
|
Patient Health Questionnaire-Adolescent (PHQ-A, 9 items plus 4 follow-up items, self-report, 3-point Likert scale, 0-27 score range, higher score indicates more depression symptoms/severity).
|
Baseline through 12 months
|
|
Depressive and mental disorder episodes
Time Frame: Baseline through 12 months
|
Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI Kid, self-report).
This is a structured psychiatric interview administered by a trained staff member which uses stem questions and follow-ups to determine the presence of symptoms and date of onset.
The staff member then determines if and when the symptoms developed an episode is present.
Measure is either episode present or not and date of onset.
|
Baseline through 12 months
|
|
Stress symptoms
Time Frame: Baseline through 12 months
|
Center for Epidemiological Studies-Depression Scale (CES-D, 20 items, self-report, measured in frequency, 0,"not at all" to 3, "nearly every day in last week, 0-60 score range, higher score indicates more depressed).
|
Baseline through 12 months
|
|
Resiliency
Time Frame: Baseline through 12 months
|
Resiliency will be measured across multiple domains.
To assess resiliency in terms of coping skills, the Connor-Davidson Resilience Scale (CD-RISC, 10 items, self-report, 4 levels of response, 0-40 score range, higher score indicates better coping skills).
|
Baseline through 12 months
|
|
Function
Time Frame: Baseline through 12 months
|
Social Adjustment Scale Self-Report (SAS-SR, 23-items, self-report, 5-point Likert scale, 23-115 score range, higher score indicates higher levels of social adjustment) administered to adolescents only.
|
Baseline through 12 months
|
|
Relationships (Life Events)
Time Frame: Baseline through 12 months
|
University of California at Los Angeles (UCLA) Life Events Scale (19-items, self-report) administered to adolescents only.
|
Baseline through 12 months
|
|
Socio-cultural Relevance
Time Frame: Baseline through 12 months
|
The Socio-Cultural Relevance Scale (10-item and 14-item versions, self-report, 5-point Likert scale, 10-40 or 14-56 score ranges, higher score indicates greater socio-cultural relevance) will assess perceived change and satisfaction with the intervention, component of cultural acceptability to adolescent)
|
Baseline through 12 months
|
|
Acceptability of Intervention
Time Frame: Start to end of recruitment, 32 months
|
Acceptability of Intervention Measure (AIM, 1 question with 4 items, self-report, 5-point Likert scale, 1-5 score range, higher score indicates greater acceptability of intervention, to be completed by all staff and leadership, repeatedly, component of cultural acceptability to practice, community center, healthcare organizations, health systems).
|
Start to end of recruitment, 32 months
|
|
Feasibility of Intervention
Time Frame: Start to end of recruitment, 32 months
|
Feasibility of Intervention Measure (FIM, 1 question with 4 items, self-report, 5-point Likert scale, 1-5 score range, higher score indicates greater feasibility of intervention, to be completed by all staff and leadership, repeatedly, component of cultural acceptability to practice, community center, healthcare organizations, health systems).
|
Start to end of recruitment, 32 months
|
|
Intervention Appropriateness
Time Frame: Start to end of recruitment, 32 months
|
Intervention Appropriateness Measure (IAM, 1 question with 4 items, self-report, 5-point Likert scale, 1-5 score range, higher score indicates greater appropriateness of intervention, to be completed by all staff and leadership, repeatedly, component of cultural acceptability to practice, community center, healthcare organizations, health systems).
|
Start to end of recruitment, 32 months
|
|
Externalizing Behavior Symptoms
Time Frame: Baseline through 12 months
|
Disruptive Behavior Disorders Rating Scale-Adolescent (DBD-A, 41-items, self-report, 4-point Likert scale, 0-123 score range, higher score indicates greater externalizing symptoms).
|
Baseline through 12 months
|
|
Anxiety Symptoms
Time Frame: Baseline through 12 months
|
Screen for Child Anxiety Related Disorders (SCARED, 41-items, self-report, 3-point Likert scale, 0-82 score range, higher score indicates greater anxiety symptoms).
|
Baseline through 12 months
|
|
Substance Abuse Symptoms
Time Frame: Baseline through 12 months
|
Car, Relax, Alone, Forget, Friends, Trouble substance use assessment (CRAFFT, 6 items, self-report, 2-point scale, 0-6 score range, higher score indicates greater substance abuse symptoms).
|
Baseline through 12 months
|
|
Post Traumatic Stress Disorder Symptoms
Time Frame: Baseline through 12 months
|
Child Post Traumatic Symptoms Disorder Scale (24-items, self-report, 4-point Likert scale, 0-72 score range, higher score indicates greater PTSD symptom levels).
|
Baseline through 12 months
|
|
Rumination
Time Frame: Baseline through 12 months
|
Tendency towards rumination will be assessed by the Children's Response Style Scale (CRSS, 10-items, self-report, 5-point Likert scale, 0-50 score range, higher score indicates greater rumination (more repeated negative thinking, less resilient, component of resiliency).
|
Baseline through 12 months
|
|
Dysfunctional Attitudes
Time Frame: Baseline through 12 months
|
The Dysfunctional Attitude Scale (DAS, 9-item, self-report, 7-point Likert scale, 9-63 score range, higher score indicates more dysfunctional attitude, less resiliency, component of resiliency).
|
Baseline through 12 months
|
|
Family Relationships
Time Frame: Baseline through 12 months
|
Child Report of Parental Behavior Inventory (CRPBI, 30-item, self-report, 3-point Likert scale, 0-60 score range, higher scores indicate more positive parent child relationship).
|
Baseline through 12 months
|
|
Cognitive Style
Time Frame: Baseline through 12 months
|
The Children's Cognitive Style Questionnaire (CCSQ, 6-items, self-report, 5-point Likert scale, 0-150 range, higher score indicates greater negativity of cognitive style).
|
Baseline through 12 months
|
|
Self-efficacy
Time Frame: Baseline through 12 months
|
The Trans-Theoretical Model Scale (TTMS, 10-item, self-report, 4-point Likert scale, 0-24 range, higher score indicates higher self-efficacy and intention to reduce depressive symptoms).
|
Baseline through 12 months
|
|
Social Adjustment
Time Frame: Baseline through 12 months
|
The Social Adjustment Scale-Adolescent version (SAS-SR, 23-item, self-report, 5-point Likert scale, 0-115 range, higher score indicates higher level of social dysfunction).
|
Baseline through 12 months
|
|
Systolic and diastolic blood pressure
Time Frame: At baseline
|
Measured in millimeters of mercury.
|
At baseline
|
|
Height
Time Frame: At baseline
|
Measure by standard medical office practice measure, without shoes, in centimeters.
|
At baseline
|
|
Weight
Time Frame: At baseline
|
Measured in kilograms by standard medical office scale, fully clothed participant.
|
At baseline
|
|
Body Mass Index
Time Frame: At baseline
|
Calculated by measuring height (centimeters) and weight (kilogram) to calculate kg/meters squared (BMI, Body Mass Index).
|
At baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Moderation of COVID-19-related behaviors and consequences
Time Frame: Baseline through 12 months
|
The investigators will examine COVID-19-related behaviors and consequences (e.g.
social distancing, sheltering-in-place, family illness and death) that that may be moderators of study outcomes using the Holliston at-Home Questionnaire (a 40-item, adolescent self-report, 5-point Likert scale, 0-150 score range, higher score indicates greater behaviors and consequences).
|
Baseline through 12 months
|
|
Moderation of COVID-19-related social determinants of health
Time Frame: Baseline through 12 months
|
The investigators will examine COVID-19-related social determinants of health (e.g.
food insecurity, internet access, unemployment) that may be moderators of study outcomes using the Holliston at-Home Questionnaire (a 40-item, adolescent self-report, 5-point Likert scale, 0-150 score range, higher score indicates greater number of social determinants).
|
Baseline through 12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Benjamin W Van Voorhees, MD, MPH, UIC, College of Medicine
- Principal Investigator: Tracy RG Gladstone, PhD, Wellesley College
- Study Director: Calvin Rusiewski, MBBS, UIC, College of Medicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2022
Primary Completion (Actual)
October 31, 2024
Study Completion (Estimated)
October 31, 2026
Study Registration Dates
First Submitted
January 10, 2022
First Submitted That Met QC Criteria
January 10, 2022
First Posted (Actual)
January 24, 2022
Study Record Updates
Last Update Posted (Estimated)
January 8, 2026
Last Update Submitted That Met QC Criteria
January 6, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHAIRb 20080601
- 1R01MH124723-01 (U.S. NIH Grant/Contract)
- 3R01MH124723-04S1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
Clinical Trials on Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
-
University of Alabama at BirminghamBaylor College of Medicine; Yale University; National Center for Complementary...RecruitingConvulsion, Non-Epileptic | Functional SeizuresUnited States
-
University of Illinois at ChicagoUniversity of California, Los Angeles; University of Chicago; Wellesley College; The Arc of IllinoisEnrolling by invitationDepression | Anxiety | TransitionUnited States
-
Florida State UniversityUnited States Department of Defense; Invisible Wounds ProjectNot yet recruitingPTSD - Post Traumatic Stress Disorder | TBI-Traumatic Brain InjuryUnited States
-
National Institute of Diabetes and Digestive and...WithdrawnObesity | OverweightUnited States
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA)Active, not recruitingPosttraumatic Stress Disorder | Polysubstance AbuseUnited States
-
The Hong Kong Polytechnic UniversityRecruitingElectroencephalography | Autism Spectrum Disorder (ASD) | Transcranial Direct Current Stimulation (tDCS)Hong Kong
-
The Hong Kong Polytechnic UniversityRecruitingPost-Concussion Syndrome | Functional Magnetic Resonance Imaging | Transcranial Direct Current Stimulation | Magnetic Resonance SpectroscopyHong Kong
-
The National Brain Mapping Laboratory (NBML)Mohaghegh Ardabili UniversityCompletedMultiple SclerosisIran
-
Florida International UniversityTerminatedAttention Deficit Hyperactivity DisorderUnited States
-
University of WashingtonNational Institute on Drug Abuse (NIDA); Kaiser PermanenteCompleted